A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Enquire about " Apixaban Impurity 132 - 70173-70-5"

Need help?
Picture of Apixaban Impurity 132

Apixaban Impurity 132

SZ CAT No: SZ-A062173
CAS No
70173-70-5
Mol.F.
C14H15N3O2
Mol.Wt.
257.3
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name: 3-Methoxy-4-((4-methoxyphenyl)diazenyl)aniline

Shipping Temperature: Room Temperature

HSN Code: 38229010

Country of Origin: India

Smiles: NC(C=C1OC)=CC=C1/N=N/C2=CC=C(C=C2)OC

Apixaban Impurity 132 is chemically 3-Methoxy-4-((4-methoxyphenyl)diazenyl)aniline. Apixaban Impurity 132 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 132 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 70173-70-5

Purchase 70173-70-5

Order 70173-70-5

Enquire 70173-70-5

price of 70173-70-5

70173-70-5 Supplier

70173-70-5 Manufacturer

70173-70-5 Exporter

buy high quality Apixaban Impurity 132

Purchase Apixaban Impurity 132

Apixaban Impurity 132 suppliers

Apixaban Impurity 132 manufacturers

Apixaban Impurity 132 price

Apixaban Impurity 132 Exporter

Order Apixaban Impurity 132

Enquire Apixaban Impurity 132

Apixaban Impurity 132 cost

Apixaban Impurity 132 Supplier

Apixaban Impurity 132 Distributor

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,